Biome Analytics, a leader in cardiovascular performance analytics, announces the launch of its newest module designed to enhance data-driven decision-making for ECMO, heart transplant, and LVAD programs.
This advanced analytics module delivers deep insights into patient outcomes, program efficiency, and resource utilization by integrating clinical, operational, and financial data. Developed in collaboration with leading transplant and mechanical circulatory support (MCS) centers, the module enables cardiovascular teams to benchmark performance, optimize patient selection, and refine protocols for better clinical and financial outcomes.
Also Read: Egnyte & Espero Partner on AI-Powered Clinical Trial Solutions
“As ECMO, heart transplant, and LVAD programs grow in complexity, actionable analytics are essential for delivering advanced therapies effectively and monitoring their impact on both patients and healthcare organizations,” said Amber Pawlikowski MSN, RN, CPHQ, Vice President of Performance Improvement at Biome Analytics. “This module provides unprecedented visibility into key performance indicators, empowering programs to improve care pathways and operational sustainability.”
Source: Businesswire
